PharmaCyte Biotech, Inc.
New Filing
CIK: 0001157075·Biotechnology·NEVADA·Filed: Sep 1, 2021
Total Offering
$70,000,000
Amount Sold
$70,000,000
Investors
19
First Sale
Aug 23, 2021
Offering Details
- Type
- Equity, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Kenneth L. Waggoner | Related Person |
| Carlos A. Trujillo | Related Person |
| Crabtree W. Crabtree | Related Person |
| Thomas C.K. Yuen | Related Person |
| Michael M. Abecassis | Related Person |
| Raymond CF Tong | Related Person |
| Thomas Liquard | Related Person |
Company
SEC Filing
0001683168-21-004022
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free